Deaconess Receives New COVID-19 Treatment for High-Risk Patients

Deaconess says it has received a newly-released COVID-19 treatment that will be used to treat mild-to-moderate cases of COVID-19 in patients who are at high risk of progressing to severe COVID-19 and/or hospitalization.

Wevv dot com.

But deaconess isn't just testing patients it's also treating them with eli lilly's new antibody drug.

We first reported on friday --- 2750 doses were distributed across indiana.

We now know --- 180 doses were given to deaconess hospitals.

Since it's arrival -- doctors were able treat 30